/_media/adv/web/images/2010/20100210_NDSSI_TB-378x82.gif

Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
Outpatient Surgery E-Weekly

Study: Anesthesia Awareness May Trigger Post-Traumatic Stress Disorder

Nearly two-thirds of patients who experienced intraoperative awareness suffered from post-traumatic stress disorder 5 years after their surgeries, a...

Trained Providers Lower Propofol Risks

The airway complication risks associated with the use of propofol during advanced endoscopic procedures are lower when trained professionals deliver...

Wrong-Site Errors Plague Nerve Blocks, Too

A study examining the frequency and causes of wrong-site injections in pain management procedures recommends strict use of the Universal Protocol in...

Archive > June, 2008 Vol. IX, No. 6
This Just In
Lobbyist Supreme

From the Top
ASCA President Kathy Bryant Discusses the Merger, Medicare and How to Make an Impact
The Ambulatory Surgery Center Association's "ASCs 2008" conference last month in San Antonio, the group's first outing as the industry's sole representative body, marked a milestone while strengthening ASCs' voices, says association President Kathy Bryant.

Categories: Business Management, Gastroenterology, Infection Control, Legal/Regulatory, News
Already have an account? Please sign in:
Email Address:
Password:
PRODUCT & SERVICE RESOURCES
Product & Service Showcase
A showcase of products and services geared to make your facility better.
Professional Services Platinum Pages
A guide of people and companies to help make your facility better.
Products In This Issue
Make sure it is green.

MegaDyne

SSI? Not on my watch.

Kimberly-Clark

People of vision.

Vantage Technology

Do not allow smoking in your OR.

Buffalo Filter

Other Articles That May Interest You
FDA Panel Recommends Drug to Prevent DVT
If approved, rivaroxaban would be marketed for use in patients undergoing hip and knee replacements.
AMO Recalls Vitrax II
pH of some of the viscoelastic found to be higher than normal.
FDA Warns of Retained Tissue in Arthroscopic Shavers
Agency urges facilities to evaluate cleaning processes and report problems.
Comment on this Article
Please login to leave a comment on this article.
Recent Comments
Please login to read comments on this article.